Literature DB >> 31756649

Fluoroquinolone antibiotics show genotoxic effect through DNA-binding and oxidative damage.

Prabuddha Bhattacharya1, Srasta Mukherjee2, Santi M Mandal3.   

Abstract

The fluoroquinolones (FQs) are one the most successful class of synthetic antibiotics that primarily target the type II topoisomerases. With a pursuit to evaluate their genotoxicity, the present work established moderate to good DNA-damaging properties of some of the well-known and clinically prescribed fluoroquinolone antibiotics (2nd and 3rd generation). Hypochromic shift in UV-Vis absorption titration, fluorescence quenching in competitive ethidium bromide displacement assay (with calf-thymus DNA) and in-silico studies established DNA-intercalation with binding constants of the order 104. A basic Structure Activity Relationship (SAR) has been derived from the docking results. MTT assay has been also done to evaluate the effect of these antibiotics on cell viability. The expression level of specific DNA-glycosylase enzymes responsible for repairing the oxidized DNA bases are quantified through western blot analysis. The studies revealed that fluoroquinolone antibiotics initiate the genotoxic effect at a concentration of above 50 μg/mL. Recruitment of APE1 and NEIL1 was found to be significantly increased to remove the oxidized nucleobases.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Docking; Ethidium bromide; Fluorescence; Fluoroquinolones; Genotoxicity; MTT assay; ROS; UV–Vis absorption; Western immunoblotting assay

Mesh:

Substances:

Year:  2019        PMID: 31756649     DOI: 10.1016/j.saa.2019.117634

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

Review 1.  Antimutagenic Activity as a Criterion of Potential Probiotic Properties.

Authors:  Evgeniya V Prazdnova; Maria S Mazanko; Vladimir A Chistyakov; Anna A Bogdanova; Aleksandr G Refeld; Evgeniya Y Kharchenko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-14       Impact factor: 4.609

2.  Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy.

Authors:  Dagmara Grot; Katarzyna Wasiak; Jerzy Tyszkowski; Ewelina Stoczynska-Fidelus; Tomasz P Ochedalski; Piotr Rieske
Journal:  Stem Cell Res Ther       Date:  2022-05-21       Impact factor: 8.079

3.  Interaction of synthetic antimicrobial peptides of the Hylin a1 family with models of eukaryotic structures: Zwitterionic membranes and DNA.

Authors:  Gabriel S Vignoli Muniz; Lilia I De la Torre; Evandro L Duarte; Esteban N Lorenzón; Eduardo M Cilli; Andrea Balan; M Teresa Lamy
Journal:  Biochem Biophys Rep       Date:  2020-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.